9,837 followers
RT @StanMehr: See our latest contribution to the literature on the state of US market access to #biosimilars. https://t.co/OoUfHTXul3 .
RT @StanMehr: See our latest contribution to the literature on the state of US market access to #biosimilars. https://t.co/OoUfHTXul3 .
See our latest contribution to the literature on the state of US market access to #biosimilars. https://t.co/OoUfHTXul3 .
I've just published a new article with my co-author Rich Brook: #Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?" https://t.co/OoUfHTXul3